Trials / Conditions / Prostate Cancer Patients Undergoing Radical Prostatectomy

Prostate Cancer Patients Undergoing Radical Prostatectomy

8 registered clinical trials studyying Prostate Cancer Patients Undergoing Radical Prostatectomy — 4 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	PSMA-Targeted Intraoperative Fluorescent Imaging Agents (DGPR1008): Validation Across Different Time Windows NCT07387510	Haitao Niu, MD	Phase 2
Not Yet Recruiting	Ejaculatory Behavior and Seminal Vesicle Size During Radical Prostatectomy NCT07243795	National Taiwan University Hospital	N/A
Recruiting	Limited Versus Extended Lymph Node Dissection During Radical Prostatectomy in Patients With Localized or Local NCT07308990	N.N. Alexandrov National Cancer Centre	N/A
Completed	Safety and Efficacy Trial of a Targeted PSMA Fluorescent Contrast Agent (DGPR1008) for Intraoperative Imaging NCT07024030	Haitao Niu, MD	Phase 2
Recruiting	FK-PC101 as Adjuvant Therapy for Men With High-Risk Prostate Cancer NCT06636682	Cellvax Therapeutics Inc	Phase 2
Completed	Research on PSMA-Targeted Intraoperative Fluorescent Imaging Agents NCT07101354	Haitao Niu, MD	Phase 1
Completed	Advanced Pelvic Floor Training Program for Prostate Cancer Surgery NCT02233608	University of Guelph-Humber	Phase 1 / Phase 2
Completed	Prehabilitation for Prostate Cancer Surgery NCT02036684	University of Guelph-Humber	Phase 1 / Phase 2